Chinese biotech firm Varnotech snaps $84m Series B funding

Vaccine developer Varnotech has secured 600 million yuan ($84 million) in a Series B funding round co-led by Beijing Pharmaceutical and Healthcare Industry Investment Fund, a 20-billion-yuan ($2.8 billion) fund set up by Beijing State-owned Capital Operation and Management Company.